• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA OKs Roche's Nasal Swab MRSA Test

    Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs

    Eye Test for Parkinson's Gains Breakthrough Designation

    Biomerics Forms New Business Unit

    J&J's New Monofocal IOL for Cataract Patients with Astigmatism
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Lyons

    K-Tube Technologies

    Marox Corporation

    RJG Inc.

    Glenbrook Technologies Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Understanding Key Processes for Mixing APIs with Silicone

    How to Minimize Color Variations in Your Medical Device

    Don’t Touch: Gesture Tech Is Reshaping How We Interact with Devices

    Revenue-Based Financing: A New Form of Growth Capital

    Pre-Filled Safety Syringes and the Self-Administration Trend
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Aran Biomedical

    Lyons

    IQMS

    Halkey-Roberts Corporation

    Marox Corporation
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA Approves Cardiva Medical's VASCADE MVP Vascular Closure System for Multi-Site Vessel Closure

    Potential procedures include cardiac ablation and left atrial appendage closure, among others.

    FDA Approves Cardiva Medical
    VASCADE MVP Venous Vascular Closure System. Image courtesy of Cardiva Medical Inc.
    Related CONTENT
    • FDA Clears Surgical Innovation Associates' Bioabsorbable Mesh for Reconstructive & Cosmetic Surgery
    • FDA Clears Siemens Healthineers’ MRI Scanner
    • Biocompatibility Pulse Check: How FDA’s New Requirements Affect Our Industry
    • FDA Approves New DNA-Based Test to Determine Blood Compatibility
    • AVITA Medical Receives FDA Approval of the RECELL System for Burn Treatment
    Business Wire02.04.19
    Cardiva Medical Inc., an innovator in the field of vascular closure, has received PMA approval from the U.S. Food and Drug Administration (FDA) for the VASCADE MVP Venous Vascular Closure System. VASCADE MVP is the first and only vascular closure system designed and labeled specifically for multi-site venous closure— for 6-12 French inner diameter sheaths. This access site approach and size range is the standard in electrophysiology procedures such as cardiac ablation and left atrial appendage closure.
     
    VASCADE MVP uses a simple and proprietary delivery system to place a collagen patch on the outside of each vessel puncture site following completion of the procedure. Nothing is left behind inside the vessel, and the collagen outside the vessel wall is resorbed in a short period of time enabling reaccess for future procedures.

    “We are at the dawn of a new era now for electrophysiology procedures with this trailblazing technology,” said Suneet Mittal, M.D., director of electrophysiology and medical director of The Snyder Center for Comprehensive Atrial Fibrillation at The Valley Hospital in Ridgewood, N.J. “The improvements we have seen in both patient satisfaction and more efficient hospital workflow make this one of those rare new technologies that produces benefits for all stakeholders.”
     
    The approval is based on results of the AMBULATE Pivotal Trial, a 204-patient, 13-site randomized, controlled study of the VASCADE MVP System compared to standard manual compression following cardiac ablation. The study showed significant improvements in time to ambulation, total post-procedure time and time-to-discharge eligibility, as well as improved patient satisfaction scores and reduced use of opioid pain medications. Results of the trial were presented at the 2018 AHA Scientific Sessions by Andrea Natale, M.D., co-principal investigator and executive medical director, Texas Cardiac Arrhythmia Institute in Austin, Texas.
     
    “With the VASCADE MVP device, we have been able to get patients safely on their feet hours earlier than previously possible after an ablation for atrial fibrillation or a left atrial appendage closure procedure,” said Amin Al-Ahmad, M.D., electrophysiologist at Texas Cardiac Arrhythmia Institute. “In our practice the new Cardiva workflow has freed up staff and beds—and patient satisfaction has skyrocketed with less time spent immobilized on their backs. This new workflow may also make it possible to send more patients home the same day as their procedure.”
     
    “Approval of the VASCADE MVP System marks the culmination of a multi-year effort by Cardiva to pioneer the first dedicated vessel closure solution for electrophysiology procedures such as cardiac ablation and left atrial appendage closure,” said John Russell, CEO of Cardiva Medical. “We are proud to have partnered with leading EP physicians in the United States to address this unmet need—and enable patients to get back on their feet sooner and improve the workflow for these highly successful procedures. This approval—our second PMA approved product—is an exciting milestone for our team, and shipments to leading centers in the United States have already begun.”
     
    VASCADE MVP is a new vessel closure device designed specifically for electrophysiology procedures and built upon the established and clinically proven VASCADE system, which has been used with over 300,000 patients.
     
    A fully integrated, extravascular, bioabsorbable femoral access closure system, VASCADE MVP is easy to use and leaves no permanent components behind. The system combines Cardiva’s proven proprietary collapsible disc delivery system and a thrombogenic resorbable collagen patch in an integrated design.
     
    VASCADE MVP works by placing a small, collapsible mesh disc against the inside of the vessel wall to temporarily stop the bleeding, releasing a collagen patch into the tissue tract and then removing the mesh disc. The collagen patch expands, providing a mechanical and physiological seal to stop the bleeding, and then absorbs into the body, leaving nothing behind and allowing further access to the vessel if additional procedures are required.
     
    VASCADE MVP is indicated for percutaneous closure of femoral venous access sites while reducing time to ambulation, total post-procedure time, time to hemostasis, and time to discharge eligibility in patients who have undergone catheter-based procedures utilizing 6-12F inner diameter procedural sheaths, with single- or multiple-access sites in one or both limbs.
     
    The AMBULATE study was a randomized, controlled clinical trial that enrolled 204 patients who underwent arrhythmia ablation procedures by 28 physicians at 13 sites across the United States. All patients had multiple (3 or 4) mid-bore (6-12 Fr inner diameter sheath) femoral venous access sites, and were randomized into one of two groups. The treatment group had all sites closed with the VASCADE MVP system, while the control group had all sites closed using manual compression, which is the current standard of care. Patients were enrolled with both radiofrequency and cryo energy sources used in their procedures. Principal investigators include Andrea Natale, M.D.; Mintu Turakhia, M.D., associate professor, Stanford University School of Medicine; and Steve Compton, M.D., Alaska Heart and Vascular Institute.

    Compared to manual compression, the Vascade MVP System met all primary and key secondary endpoints, including:
    • Time to Ambulation (primary endpoint). A measure of how quickly patients are able to get up on their feet and walk following vessel closure. The VASCADE MVP arm showed a median reduction of 3.9 hours (2.2 hours vs. 6.1 hours, p-value < 0.0001).
    • Total Post-Procedure Time. The VASCADE MVP arm showed a mean reduction of 3.7 hours in the total time from completion of the ablation procedure to the patient walking. This was inclusive of the time to achieve vessel closure (3.1 hours vs. 6.8 hours, p-value <0.0001).
    • Time-to-Discharge Eligibility. VASCADE MVP reduced the mean time for patients to be deemed eligible for discharge by 3.4 hours (3.1 hours vs. 6.5 hours, p-value < 0.0001).
    • Patient Satisfaction. The patient-reported level of satisfaction with the duration of bed rest was 63 percent higher in the VASCADE MVP arm (8.3 score out of 10 vs. 5.1 out of 10, nominal p-value <0.0001).
    • Opioid Pain Medications. 58 percent fewer patients in the VASCADE MVP arm used opioid-class pain medications following their procedure (15 percent of patients vs. 36 percent of patients, nominal p-value 0.001).

    Additional studies in the industry-leading AMBULATE series include:
    • AMBULATE IMPACT Study: A recently completed study that examines today’s workflow following ablation procedures with a focus on improving hospital economics through early patient ambulation and improved workflow. Results from the AMBULATE IMPACT study will be published in 2019.
    • AMBULATE CAP Study: A continued access protocol study designed to evaluate the safety of VASCADE MVP with earlier hospital discharge, elimination of urinary catheters, and elimination of protamine drug use in the setting of electrophysiology procedures. The AMBULATE CAP protocol recently completed enrollment with 168 patients enrolled at three centers.
    Cardiva Medical Inc. is a privately held medical device company focused on developing and commercializing vascular closure technologies. The company is headquartered in Santa Clara, Calif.

    VASCADE and Cardiva Catalyst and VASCADE MVP are registered trademarks of Cardiva Medical Inc.
    Related Searches
    • impact study
    • heart
    • technology
    • body
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    Latest Steps to Strengthen FDA’s 510(k) Program for Premarket Review Latest Steps to Strengthen FDA’s 510(k) Program for Premarket Review
    Chief Financial Officer at Senseonics Holdings to Retire Chief Financial Officer at Senseonics Holdings to Retire
    FDA FDA's New Actions Concerning the Digital Health Pre-Cert Pilot Program
    Device to Objectively Assess Pressure Ulcer Risk Wins De Novo Clearance Device to Objectively Assess Pressure Ulcer Risk Wins De Novo Clearance
    CardioMech Appoints President and CEO CardioMech Appoints President and CEO
    Retia Medical’s Argos Cardiac Output Patient Monitor Cleared Retia Medical’s Argos Cardiac Output Patient Monitor Cleared
    Hologic’s Cynosure Division Launches TempSure Surgical RF Technology Hologic’s Cynosure Division Launches TempSure Surgical RF Technology
    AVITA Medical Begins Clinical Study of RECELL System in Pediatric Burn Treatment AVITA Medical Begins Clinical Study of RECELL System in Pediatric Burn Treatment
    Hill-Rom & EarlySense Launch Patient Monitoring Technology for Centrella Smart+ Beds Hill-Rom & EarlySense Launch Patient Monitoring Technology for Centrella Smart+ Beds
    Subtle Medical Subtle Medical's SubtlePET Gains FDA Clearance & CE Mark
    First Patient Treated in Medtronic First Patient Treated in Medtronic's TERMINATE AF Clinical Trial
    Deciphering Dosage: A Focus on Combination Products Deciphering Dosage: A Focus on Combination Products
    MPO Summit: The View from the Top MPO Summit: The View from the Top
    RSNA News: Siemens Healthineers Debuts MAGNETOM Altea 1.5T MR Scanner RSNA News: Siemens Healthineers Debuts MAGNETOM Altea 1.5T MR Scanner
    New Efforts to Strengthen FDA’s Expanded Access Program New Efforts to Strengthen FDA’s Expanded Access Program

    Related Breaking News

    • Cardiovascular | Patient Monitoring
      VivaLNK Wearable Sensor and Software Development Kit Receive CE Mark

      VivaLNK Wearable Sensor and Software Development Kit Receive CE Mark

      The reusable patch weighs only 7.5 grams.
      PRNewswire 12.03.19

    • Cardiovascular | Surgical
      CryoLife

      CryoLife's Thoraco-abdominal Stent Graft Gains CE Mark

      First off-the-shelf option with pre-cannulated inner branch technology.
      PR Newswire 12.03.19

    • Cardiovascular
      Concept Medical Granted CE Certification for its Sirolimus Coated MagicTouch Group of Products

      Concept Medical Granted CE Certification for its Sirolimus Coated MagicTouch Group of Products

      Company is now focused on marketing the products in Europe.
      Businesswire 11.25.19


    • Cardiovascular
      Bristol-Myers Squibb-Pfizer Alliance, Fitbit Partner to Address Gaps in Afib Detection

      Bristol-Myers Squibb-Pfizer Alliance, Fitbit Partner to Address Gaps in Afib Detection

      Companies are joining forces to develop atrial fibrillation educational content to help identify and support those at increased risk of stroke.
      Businesswire 11.25.19

    • Cardiovascular | Digital Health
      Biofourmis Partners with Novartis

      Biofourmis Partners with Novartis

      Teams up to offer digital therapeutics for patients with heart failure.
      Biofourmis 11.19.19

    • Cardiovascular
      First Patient in Middle East Treated With CSI

      First Patient in Middle East Treated With CSI's Peripheral Orbital Atherectomy Technology

      Introduction of Orbital Atherectomy expands treatment options for patients with peripheral artery disease.
      Business Wire 11.19.19


    • Cardiovascular | Materials | Tubing & Extrusion
      CVC Manufactured from Special Urethane Material that Becomes Softer in the Body

      CVC Manufactured from Special Urethane Material that Becomes Softer in the Body

      Optimized design of central venous catheters reduces risk of complications.
      Flexan 11.18.19

    • Cardiovascular | Digital Health | Patient Monitoring | Software & IT
      Preventive Healthcare via Apps

      Preventive Healthcare via Apps

      Prevention through digital helpers from Fraunhofer and partners.
      Fraunhofer-Gesellschaft 11.18.19

    • Cardiovascular | Contract Manufacturing | Materials | Tubing & Extrusion
      Freudenberg Medical Launches Wave of Product and Process Innovations

      Freudenberg Medical Launches Wave of Product and Process Innovations

      Among new innovations is Helix iMC, a new technology to continuously measure the inner geometry of silicone tubes.
      Freudenberg Medical 11.18.19


    • Cardiovascular | Neurological | Surgical
      Neural Networks Enable Autonomous Navigation of Catheters

      Neural Networks Enable Autonomous Navigation of Catheters

      AI support for endovascular stroke therapy.
      Fraunhofer-Gesellschaft 11.18.19

    • Cardiovascular
      PQ Bypass Receives Unconditional IDE Approval From FDA to Start TORUS SFA Stent Graft Study

      PQ Bypass Receives Unconditional IDE Approval From FDA to Start TORUS SFA Stent Graft Study

      TORUS-2 marks second Investigational Device Exemption approved for company in less than two years.
      Business Wire 11.15.19

    • Cardiovascular | Patient Monitoring | Software & IT
      FDA OKs Ultromics

      FDA OKs Ultromics' AI-Powered Decision Support System

      AI automates cardiac analysis helping earlier detection of cardiovascular disease, enabling clinicians to improve patient care and outcomes.
      PR Newswire 11.14.19

    • Cardiovascular
      THI’s Research Team Receives a Federal Grant

      THI’s Research Team Receives a Federal Grant

      Is developing a wireless and leadless pacemaker system.
      Texas Heart Institute 11.13.19

    • Cardiovascular
      Third-Party Evaluation Confirms Safety Profile of Philips Stellarex Low-Dose Drug-Coated Balloon

      Third-Party Evaluation Confirms Safety Profile of Philips Stellarex Low-Dose Drug-Coated Balloon

      Data show no difference in mortality between patients treated with the Philips Stellarex DCB and those treated with percutaneous angioplasty.
      Globe Newswire 11.11.19

    • Cardiovascular
      Study Shows Safety, Efficacy of Near Infrared Spectroscopy Imaging to Identify MACE Risk

      Study Shows Safety, Efficacy of Near Infrared Spectroscopy Imaging to Identify MACE Risk

      Trial identified both vulnerable patients and plaques that are at significantly higher risk for subsequent major adverse cardiac events.
      Business Wire 11.08.19


    Breaking News
    • FDA OKs Roche's Nasal Swab MRSA Test
    • Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs
    • Eye Test for Parkinson's Gains Breakthrough Designation
    • Biomerics Forms New Business Unit
    • J&J's New Monofocal IOL for Cataract Patients with Astigmatism
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    International Scientific Society Calls for Omega-3 Blood Testing in Future Research
    Pharmactive Affron Saffron May Help Relieve Depression Symptoms
    Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice
    Coatings World

    Latest Breaking News From Coatings World

    Cristo Rey High School Educator Named 2019 Axalta All-Pro Teacher of the Year
    Michelman Makes United Way of Greater Cincinnati’s List of Top 25 Corporate Campaigns
    BCF: Coatings Industry Reports Record Improvement in Waste, Recycling, Accident Rates
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs Roche's Nasal Swab MRSA Test
    Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs
    Eye Test for Parkinson's Gains Breakthrough Designation
    Contract Pharma

    Latest Breaking News From Contract Pharma

    MedPharm Triples Capacity at RTP Site
    UCB Trial Achieves Endpoints
    PhRMA Appoints Federal Advocacy SVP
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Pantone Names Classic Blue the 2020 Color of the Year
    Burst Launches Black Expanding Dental Floss
    Glossier Enters Nordstrom for the Holidays
    Happi

    Latest Breaking News From Happi

    Raining Rose Expands Exec Team
    Scott’s Sells Personal Care Production Site
    Givaudan Unveils RitualEssenz Brazil
    Ink World

    Latest Breaking News From Ink World

    ePac Flexible Packaging Expands into Asia Pacific Market
    Haney, HP Developing Sustainable Fashion Packaging for Heron Preston
    Addipel Moves to New HQ, Expands Production Facility
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    HP teams with Haney for sustainable packaging
    Tags & Labels Printing adds Heidelberg’s Versafire EP
    Austrian converter installs first Nilpeter press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Thrace to Relocate U.S. Capacity
    FiltXPO Speaker Line-Up Announced
    Nölken Incorporates Sustainable Wipes Packaging
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Appoints New Spine Business Leader
    Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    Synaptive Medical's Modus V Expands Into Spine Market
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    IDTechEx Show! Announces Graphene Award Winner
    OE-A Continues to Bring Future of Printed Electronics to CES 2020
    Avancis, Smit Thermal, HZB, CNRS, Solliace Team for Higher Efficiencies in CIGS

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.